FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1479702959> ?p ?o ?g. }

• W1479702959 endingPage "690" @default.
• W1479702959 startingPage "689" @default.
• W1479702959 abstract "The human skin circulation has a key role in thermoregulation via responses to both reflex whole-body and local thermal stimuli (Kellogg, 2006). During whole-body heat stress, a great increase in skin blood flow is necessary to dissipate body heat (Johnson & Proppe, 1996). This active vasodilatation is due to neurotransmitters such as acetylcholine, vasoactive intestinal peptide and others released from sympathetic cholinergic nerves. In addition, several studies have demonstrated that nitric oxide (NO) participated significantly in skin blood flow increase induced by whole-body heat stress (Kellogg et al. 2003; Kellogg, 2006). During local warming, increases in temperature cause localized cutaneous vasodilation via two independent mechanisms: an initial rapid peak followed by a slower vasodilator response that reaches a plateau after around 30 min of heating. Local sensory nerves are primarily responsible for the vasodilatation causing the initial rapid peak, whereas the plateau phase includes a substantial NO component (Kellogg et al. 1999). Therefore, human skin blood flow increases in response to increased body core and local skin temperature via distinct reflex and local mechanisms requiring NO production. NO generation is expressed by different NO synthase (NOS) isoforms: neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS). However, the mechanistic involvement of the different NOS isoforms in the vasodilatory response to heat stress, in vivo, remains still unknown. In this issue of The Journal of Physiology, Kellogg et al. (2007) reported that cutaneous vasodilatation induced by both local and whole-body heating was (at least in part) a NO-dependent process that could involve two distinct NOS isoforms (eNOS and nNOS). This paper is very interesting since the authors demonstrated for the first time the involvement of nNOS in the active vasodilatation induced by whole-body heating in contrast to local body heating in healthy people. The protocol was designed to examine the effects of the nNOS inhibitor 7-nitroindazole (7-NI) on skin vasodilatation induced by both whole-body heating (38–39°C) and local skin heating (41.5°C). In this paper, readers will appreciate the importance and difficulty of identifying cellular mechanisms in physiological conditions. Indeed, 7-NI was administrated by intradermal microdialysis (2 mm) allowing large local drug concentration with local effects at the site of administration and thus avoiding systemic effects. Data were normalized to the SNP-induced maximal vasodilatation performed at the end of each protocol. Changes in skin blood flow were monitored by laser–Doppler flowmetry (LDF) that gives continuous beat-to-beat information specific to cutaneous microvascular perfusion in a non-invasive manner. LDF measurements provide a robust approach to evaluate mechanisms of microvascular dilatation and their modification by physiological perturbations. The study reported that during nNOS inhibition, the skin vasodilatation due to whole-body heating was attenuated (∼30%) in contrast to local skin heating. The authors demonstrated that, in vivo, the nNOS isoform is responsible for NO generation during centrally mediated, reflex cutaneous active vasodilatation in whole-body heating, but is not involved in increasing skin blood flow in response to axon reflex-mediated, local skin heating. This study also showed that the nNOS isoform generates NO from the very initial phase of cutaneous active vasodilatation and continues during prolonged whole-body heat stress. However, Kellogg et al. (2008) strongly suggest that NO acts to increase synergistically the vasodilating effects of other neurotransmitters rather than acting as a direct mediator of vasodilatation. Interestingly, they excluded any participation of eNOS in centrally mediated reflex cutaneous active vasodilatation since studies using l-NAME, a non-selective isoform NOS antagonist, reported approximately an identical attenuation of 30% of skin blood flow increases to that of 7-NI, a selective nNOS antagonist, highlighting the possibility that nNOS is the sole NOS isoform involved in NO generation during whole-body heat stress. Conversely, since previous studies reported an inhibitory effect of a non-selective isoform of the NOS antagonist, l-NAME, on skin vasodilatation induced by local skin heating whereas a selective nNOS antagonist, 7-NI had no effect (Kellogg et al. 2007), and given that iNOS is not expressed in healthy skin, the authors strongly suggest that eNOS is the isoform that mediates peripheral, axon reflex vasodilatation during local skin heating. The alteration of the microvasculature to dilate has significant deleterious effects leading to cardiovascular diseases occurring in ageing and several pathologies (Charkoudian, 2003). In type 2 diabetes mellitus, the ability of skin blood vessels to dilate is impaired, probably contributing to the increased risk of internal hyperthermia during exposure to elevated ambient temperatures. Raynaud phenomenon and erythromelalgia appear to relate to disorders of local and/or reflex thermoregulatory control of the skin circulation. In addition, changes in reproductive hormone levels during menopause substantially alter thermoregulatory control of skin blood flow contributing to the occurrence of hot flashes (Sokolnicki et al. 2007). Collectively, all these findings from Kellogg et al. (2008) and others are very important to further our understanding of vascular physiology under thermal stress. These studies also highlight the important role of in vivo investigations in advances of physiological research. Skin microcirculation is easily accessible for non-invasive measurements that allow a unique insight to detect endothelial dysfunction. Kellogg's research group have largely contributed to the subject of how the human skin adapts under thermal stress. Several questions still remain and further research is needed to clarify and better understand the whole mechanism. The more we identify the underlying mechanisms, the more we will be able to prevent or reverse any alterations." @default.
• W1479702959 created "2016-06-24" @default.
• W1479702959 creator A5007274006 @default.
• W1479702959 creator A5016589951 @default.
• W1479702959 creator A5054614536 @default.
• W1479702959 date "2008-02-01" @default.
• W1479702959 modified "2023-09-25" @default.
• W1479702959 title "In vivovasodilating mechanisms: who's NOS involved?" @default.
• W1479702959 cites W2011706236 @default.
• W1479702959 cites W2054943364 @default.
• W1479702959 cites W2111980453 @default.
• W1479702959 cites W2114742460 @default.
• W1479702959 cites W2134850367 @default.
• W1479702959 cites W2166143114 @default.
• W1479702959 doi "https://doi.org/10.1113/jphysiol.2007.149658" @default.
• W1479702959 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2375622" @default.
• W1479702959 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18245205" @default.
• W1479702959 hasPublicationYear "2008" @default.
• W1479702959 type Work @default.
• W1479702959 sameAs 1479702959 @default.
• W1479702959 citedByCount "1" @default.
• W1479702959 crossrefType "journal-article" @default.
• W1479702959 hasAuthorship W1479702959A5007274006 @default.
• W1479702959 hasAuthorship W1479702959A5016589951 @default.
• W1479702959 hasAuthorship W1479702959A5054614536 @default.
• W1479702959 hasBestOaLocation W14797029592 @default.
• W1479702959 hasConcept C100564792 @default.
• W1479702959 hasConcept C120770815 @default.
• W1479702959 hasConcept C126322002 @default.
• W1479702959 hasConcept C134018914 @default.
• W1479702959 hasConcept C185592680 @default.
• W1479702959 hasConcept C22885893 @default.
• W1479702959 hasConcept C2775910092 @default.
• W1479702959 hasConcept C2777622882 @default.
• W1479702959 hasConcept C2778326061 @default.
• W1479702959 hasConcept C2778843932 @default.
• W1479702959 hasConcept C2779698670 @default.
• W1479702959 hasConcept C519581460 @default.
• W1479702959 hasConcept C71924100 @default.
• W1479702959 hasConcept C83974742 @default.
• W1479702959 hasConceptScore W1479702959C100564792 @default.
• W1479702959 hasConceptScore W1479702959C120770815 @default.
• W1479702959 hasConceptScore W1479702959C126322002 @default.
• W1479702959 hasConceptScore W1479702959C134018914 @default.
• W1479702959 hasConceptScore W1479702959C185592680 @default.
• W1479702959 hasConceptScore W1479702959C22885893 @default.
• W1479702959 hasConceptScore W1479702959C2775910092 @default.
• W1479702959 hasConceptScore W1479702959C2777622882 @default.
• W1479702959 hasConceptScore W1479702959C2778326061 @default.
• W1479702959 hasConceptScore W1479702959C2778843932 @default.
• W1479702959 hasConceptScore W1479702959C2779698670 @default.
• W1479702959 hasConceptScore W1479702959C519581460 @default.
• W1479702959 hasConceptScore W1479702959C71924100 @default.
• W1479702959 hasConceptScore W1479702959C83974742 @default.
• W1479702959 hasIssue "3" @default.
• W1479702959 hasLocation W14797029591 @default.
• W1479702959 hasLocation W14797029592 @default.
• W1479702959 hasLocation W14797029593 @default.
• W1479702959 hasOpenAccess W1479702959 @default.
• W1479702959 hasPrimaryLocation W14797029591 @default.
• W1479702959 hasRelatedWork W1878567514 @default.
• W1479702959 hasRelatedWork W2018947276 @default.
• W1479702959 hasRelatedWork W2048668931 @default.
• W1479702959 hasRelatedWork W2091193879 @default.
• W1479702959 hasRelatedWork W2114204950 @default.
• W1479702959 hasRelatedWork W2115282250 @default.
• W1479702959 hasRelatedWork W2280616746 @default.
• W1479702959 hasRelatedWork W2284947444 @default.
• W1479702959 hasRelatedWork W2370601864 @default.
• W1479702959 hasRelatedWork W3112924993 @default.
• W1479702959 hasVolume "586" @default.
• W1479702959 isParatext "false" @default.
• W1479702959 isRetracted "false" @default.
• W1479702959 magId "1479702959" @default.
• W1479702959 workType "article" @default.